MedPath

MBCP Safety and Performance in the Osteonecrosis of Femur Head

Phase 2
Conditions
Osteonecrosis
Registration Number
NCT00289575
Lead Sponsor
Biomatlante
Brief Summary

The aim of this pilot study is to evaluate MBCP performance in bone regeneration after osteonecrosis biopsy of the femur head. This technic may prevent the neck of the femur bone weakness following the healthy area drilling, thanks to a bone reconstruction at the expense of the biomaterial.

Detailed Description

Twelve patients will be enrolled in this study and evaluation of infection and inflammation of the drilled area, pain and hip function will be assessed during a one year follow up. Bone reconstruction will be evaluated with scanner and radiography.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
12
Inclusion Criteria
  • femur head osteonecrosis (1 to 2 level in ARCO scale)
  • signed informed consent
Exclusion Criteria
  • primary bone infection
  • femur head sphericity loss
  • cancer, diabetes, tuberculosis previous history
  • HIV, Hepatitis B, Hepatitis C infection
  • drepanocytosis
  • current corticotherapy
  • current immunosuppressive therapy
  • innate or acquired immune deficience
  • pregnancy or lack of efficient contraception
  • current participation in an other study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Infection and inflammation of the drilled area (blood and clinical assessment).
Adverse events.
Secondary Outcome Measures
NameTimeMethod
Pain (Analogic Visual Scale)
Hip function
Bone reconstruction evaluation through scanner and radiography

Trial Locations

Locations (1)

Service de chirurgie orthopédique et traumatologique- Hôpital Pellegrin

🇫🇷

Bordeaux, France

© Copyright 2025. All Rights Reserved by MedPath